Literature DB >> 1768855

Immunohistochemical localization of N-acetylaspartate in rat brain.

J R Moffett1, M A Namboodiri, C B Cangro, J H Neale.   

Abstract

N-acetylaspartate (NAA) is one of the most prevalent compounds in the mammalian nervous system. As such, NAA largely contributes to the major peak on water-suppressed proton magnetic resonance spectra. Highly specific antibodies to NAA demonstrate that this compound is discretely localized in a substantial number of neurons throughout the extent of the rat CNS. N-acetylaspartylglutamate (NAAG) is a structurally related neuronal dipeptide which is less widely distributed than NAA. NAAG and NAA immunoreactivities were extensively colocalized in many brainstem areas, where NAAG containing neurons were more numerous than in forebrain structures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1768855     DOI: 10.1097/00001756-199103000-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  72 in total

1.  Longitudinal whole-brain N-acetylaspartate concentration in healthy adults.

Authors:  D J Rigotti; I I Kirov; B Djavadi; N Perry; J S Babb; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.

Authors:  Osamu Sasaki; Noriaki Hattori; Hajime Nakahama; Noriko Inoue; Satoko Nakamura; Takashi Inenaga; Shigeru Kohno; Tohru Sawada; Yuhei Kawano
Journal:  Neuroradiology       Date:  2006-04-04       Impact factor: 2.804

Review 3.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

4.  Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.

Authors:  N Andres Parra; Andrew A Maudsley; Rakesh K Gupta; Fazilat Ishkanian; Kris Huang; Gail R Walker; Kyle Padgett; Bhaswati Roy; Joseph Panoff; Arnold Markoe; Radka Stoyanova
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-24       Impact factor: 7.038

5.  Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.

Authors:  Brian C Schweinsburg; Michael J Taylor; Omar M Alhassoon; Raul Gonzalez; Gregory G Brown; Ronald J Ellis; Scott Letendre; John S Videen; J Allen McCutchan; Thomas L Patterson; Igor Grant
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

6.  Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression.

Authors:  Talaignair N Venkatraman; Ranga R Krishnan; David C Steffens; Allen W Song; Warren D Taylor
Journal:  Psychiatry Res       Date:  2009-04-30       Impact factor: 3.222

7.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

8.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

Review 10.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.